Palomar Health is taking early lung cancer detection to the next level.
Last month, Palomar successfully launched a minimally invasive procedure using an ION Robot — a state-of-the-art robotic-assisted bronchoscopy system designed to detect lung cancer at its earliest stages. P
“Early lung cancer detection is the cornerstone of saving lives,” said Dr. Michele Quan, Palomar Health’s lead physician working with the ION Robot. “Luckily, at Palomar Health, we can be innovative and provide a wider scope of treatment options that continue to help us reimagine the patient experience, including their cancer journey. With the ION Robot, we’re turning the tide against this devastating disease, offering patients hope and a higher chance of recovery from lung cancer.”
Palomar Health has already successfully performed three procedures using the ION Robot. One of the patients to undergo this procedure was denied biopsy methods by traditional available options. The ION Robot procedure allowed the patient to receive life-changing news about their recent diagnosis. During the procedure, Dr. Quan and her team were able to locate the nodule and obtain biopsies in under 20 minutes with the ION Robot and send it out to be tested.
Cancer continues to challenge the medical community’s understanding and treatment efforts, and according to the American Cancer Society, the leading cause of cancer death in America is lung cancer – with only a 25% survival rate over five years.
“We believe in pushing boundaries and redefining healthcare,” said Diane Hansen, President and CEO of Palomar Health. “The ION Robot program underscores our commitment to providing extraordinary care, making a meaningful impact on the lives of our patients and huge strides toward early detection and recovery, changing the patient journey entirely.”
For more information on this procedure, visit www.PalomarHealth.org.